摘要 |
The invention relates to a means of reducing or maintaining intraocular pressure, and, more particularly, to a method and composition for reducing or maintaining intraocular pressure involving the administration of a composition containing 5-trans prostaglandin F2 alpha in a pharmaceutically acceptable carrier. |